197 related articles for article (PubMed ID: 18297143)
1. Multivessel coronary artery disease: how do we treat it?
Sharma S
Timely Top Med Cardiovasc Dis; 2007 Jul; 11():E15. PubMed ID: 18297143
[No Abstract] [Full Text] [Related]
2. Medical therapy versus percutaneous coronary intervention for patients with stable coronary artery disease.
Arbab-Zadeh A
J Am Coll Cardiol; 2009 Feb; 53(6):528-9; author reply 529. PubMed ID: 19195616
[No Abstract] [Full Text] [Related]
3. [Secondary prevention of coronary heart disease. How effective are modern therapy methods?].
Kolenda KD
Dtsch Med Wochenschr; 2003 Sep; 128(36):1849-53. PubMed ID: 12964107
[No Abstract] [Full Text] [Related]
4. Letter regarding article by Hlatky et al, "medical costs and quality of life 10 to 12 years after randomization to angioplasty or bypass surgery for multivessel coronary artery disease".
Osman F; Qaisar S; Pitt M
Circulation; 2005 Apr; 111(13):e176-7; author reply e176-7. PubMed ID: 15811864
[No Abstract] [Full Text] [Related]
5. Secondary prevention of coronary artery disease.
Hall SL; Lorenc T
Am Fam Physician; 2010 Feb; 81(3):289-96. PubMed ID: 20112887
[TBL] [Abstract][Full Text] [Related]
6. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
Anselmino M; Malmberg K; Ohrvik J; Rydén L;
Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):216-23. PubMed ID: 18391651
[TBL] [Abstract][Full Text] [Related]
7. Multivessel disease: percutaneous coronary intervention for classic coronary artery bypass grafting indications.
Brar SS; Syros G; Dangas G
Angiology; 2008; 59(2 Suppl):83S-8S. PubMed ID: 18544582
[TBL] [Abstract][Full Text] [Related]
8. Secondary prevention of ischaemic cardiac events.
Gami A
Clin Evid; 2006 Jun; (15):195-228. PubMed ID: 16973010
[No Abstract] [Full Text] [Related]
9. Diabetic multivessel disease: stenting vs. coronary artery bypass grafting.
Bansilal S; Farkouh M; Sharma S; Fuster V
Indian Heart J; 2007; 59(2 Suppl B):B72-82. PubMed ID: 19153439
[No Abstract] [Full Text] [Related]
10. Cardiovascular disease in diabetes.
Sigal R; Malcolm J; Meggison H
Clin Evid; 2002 Jun; (7):498-520. PubMed ID: 12230676
[No Abstract] [Full Text] [Related]
11. Percutaneous coronary intervention versus coronary-artery bypass grafting.
Edwards JL
N Engl J Med; 2009 Jun; 360(25):2672-3; author reply 2674-5. PubMed ID: 19537314
[No Abstract] [Full Text] [Related]
12. [Treatment of coronary artery disease in a patient with adult-onset diabetes mellitus].
Syvänne M
Duodecim; 1999; 115(10):1167-73. PubMed ID: 11877856
[No Abstract] [Full Text] [Related]
13. Is the present therapy for coronary artery disease the radical mastectomy of the twenty-first century?
Esselstyn CB
Am J Cardiol; 2010 Sep; 106(6):902-4. PubMed ID: 20816134
[No Abstract] [Full Text] [Related]
14. [Stable ischemic coronary disease--medical therapy or PCI?].
Mickley H; Egstrup K
Ugeskr Laeger; 2007 Jun; 169(23):2227. PubMed ID: 17607849
[No Abstract] [Full Text] [Related]
15. Percutaneous coronary interventions for coronary artery disease: the long and short of optimizing medical therapy.
Jaumdally R; Lip GY; Varma C
Int J Clin Pract; 2005 Sep; 59(9):1070-81. PubMed ID: 16115184
[TBL] [Abstract][Full Text] [Related]
16. Hidden drugs, hidden risks--is cocaine use a new risk factor for stent thrombosis?
Lemos PA
Catheter Cardiovasc Interv; 2007 Jun; 69(7):959-60. PubMed ID: 17525956
[No Abstract] [Full Text] [Related]
17. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
Coma-Canella I
Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
[No Abstract] [Full Text] [Related]
18. [Coronary atherosclerosis].
Ebina T; Kimura K
Nihon Rinsho; 2007 Sep; Suppl 5 Pt 2():50-4. PubMed ID: 17952972
[No Abstract] [Full Text] [Related]
19. Cardiovascular disease in diabetes.
Malcolm J; Meggison H; Sigal R
Clin Evid; 2002 Dec; (8):541-68. PubMed ID: 12603899
[No Abstract] [Full Text] [Related]
20. Effect of an ongoing educational program on the use of antiplatelet drugs, beta-blockers, angiotensin-converting enzyme inhibitors, and lipid-lowering drugs in patients with coronary artery disease seen in an academic cardiology clinic.
Nayak D; Aronow WS
Cardiol Rev; 2005; 13(2):95-7. PubMed ID: 15705260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
